| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-08 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.27 | 1e-05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.28 | 3e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.28 | 7e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |